Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/annrheumdis-2021-220871 | DOI Listing |
Crit Care Resusc
December 2024
Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.
Objective: To assess current evidence regarding guanfacine use in hospitalized patients with delirium.
Introduction: Delirium is a common and important complication of critical illness. Central alpha-2 agonists are often used for symptomatic management.
This editorial explores the intricate landscape of supplement use in oncology, highlighting the growing interest and challenges surrounding their integration into cancer care. It discusses the disparity in regulatory oversight between supplements and pharmaceutical drugs, the blurred lines in their classification, and the ethical complexities in patient-doctor communication. The importance of transparency, shared decision-making, and realistic expectations is emphasized.
View Article and Find Full Text PDFN Engl J Med
January 2025
Shengjing Hospital of China Medical University, Shenyang, China
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!